Unicycive Announces Acceptance of Three Abstracts for Presentation at…
LOS ALTOS, Calif., January 23, 2023 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. UNCYa clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced